Related Experiment Videos
Haemopoietic growth factors: uses and misuses
1Department of Haematology, Sant Pau Hospital, Barcelona, Spain.
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Is cancer really a 'local' cellular clonal disease?
Medical hypotheses·2002
The importance of dose: lymphomas as a model of chemosensitive malignancies.
European journal of cancer (Oxford, England : 1990)·1993
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
European journal of cancer (Oxford, England : 1990)·1990
Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology·1990
The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.
Proceedings of the National Academy of Sciences of the United States of America·1989
Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.
European journal of cancer (Oxford, England : 1990)·2026
A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study.
European journal of cancer (Oxford, England : 1990)·2026
Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer.
European journal of cancer (Oxford, England : 1990)·2026
International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.
European journal of cancer (Oxford, England : 1990)·2026
Methodological considerations in the interpretation of ASCENT-03.
European journal of cancer (Oxford, England : 1990)·2026
Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4).
European journal of cancer (Oxford, England : 1990)·2026